2014
DOI: 10.1016/j.jpsychires.2013.10.009
|View full text |Cite
|
Sign up to set email alerts
|

Attentional and executive functions are differentially affected by post-traumatic stress disorder and trauma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
37
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(40 citation statements)
references
References 51 publications
3
37
0
Order By: Relevance
“…Our analyses did not find a significant effect of medication exclusion criteria on neurocognitive performance in PTSD, although this variable was coded dichotomously to simply reflect whether studies excluded any psychoactive medication use for at least two weeks prior to the assessment, which does not reflect chronicity of use or the variability in classes of medications (e.g., exclusion of benzodiazepines versus antidepressants). Notably, several studies that were the most conservative regarding psychotropic medication exclusion nonetheless showed neuropsychological performance deficits (Flaks et al, 2014; Geuze et al, 2009; Gilbertson et al, 2001; Golier et al, 1997; Lindauer et al, 2006; Yehuda et al, 1995), although residual performance deficits that remain even after a medication washout period cannot be excluded. In contrast, evidence from two longitudinal studies has shown that treatment with the selective serotonin reuptake inhibitor (SSRI) paroxetine not only reduces PTSD symptom severity but also increases hippocampal volumes and improves verbal memory (Fani et al, 2009; Vermetten, Vythilingam, Southwick, Charney, & Bremner, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…Our analyses did not find a significant effect of medication exclusion criteria on neurocognitive performance in PTSD, although this variable was coded dichotomously to simply reflect whether studies excluded any psychoactive medication use for at least two weeks prior to the assessment, which does not reflect chronicity of use or the variability in classes of medications (e.g., exclusion of benzodiazepines versus antidepressants). Notably, several studies that were the most conservative regarding psychotropic medication exclusion nonetheless showed neuropsychological performance deficits (Flaks et al, 2014; Geuze et al, 2009; Gilbertson et al, 2001; Golier et al, 1997; Lindauer et al, 2006; Yehuda et al, 1995), although residual performance deficits that remain even after a medication washout period cannot be excluded. In contrast, evidence from two longitudinal studies has shown that treatment with the selective serotonin reuptake inhibitor (SSRI) paroxetine not only reduces PTSD symptom severity but also increases hippocampal volumes and improves verbal memory (Fani et al, 2009; Vermetten, Vythilingam, Southwick, Charney, & Bremner, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…96 The mechanisms driving these phenomena have remained unclear, but it is worth noting that they have also been associated with concussion, 29 hypercortisolism, 71 chronic stress, 7 and PTSD, 39 offering some possible insights into convergence across these related conditions and potential mechanistic pathways. Fear (of movement, pain, or the unknown) rounds out the reactions in this primary sequela stage.…”
Section: Integration Of Recent and Emerging Evidencementioning
confidence: 99%
“…Some studies have focused on the role of frontal lobe, an area of the brain that controls the executive functions, whose impairment leads to executive dysfunction [7]. Among the cognitive impairments related to PTSD, executive dysfunction is particularly associated with negative effects on work, daily life activities, social interactions, and also some symptoms of PTSD, such as avoidance and re-experiencing the trauma [8].…”
Section: Introductionmentioning
confidence: 99%